The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Unlike the investment banks, we created StockStory to provide independent analysis that helps you determine which companies are truly worth following. That said, here are three stocks where Wall Street’s excitement appears well-founded.
Hershey (HSY)
Consensus Price Target: $205.52 (20% implied return)
Best known for its milk chocolate bar and Hershey's Kisses, Hershey (NYSE: HSY) is an iconic company known for its chocolate products.
Why Does HSY Stand Out?
- Highly efficient business model is illustrated by its impressive 18.2% operating margin
- HSY is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders, and its improved cash conversion implies it’s becoming a less capital-intensive business
- Market-beating returns on capital illustrate that management has a knack for investing in profitable ventures
Hershey’s stock price of $171.29 implies a valuation ratio of 18.4x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
agilon health (AGL)
Consensus Price Target: $118.08 (31.9% implied return)
Transforming how doctors care for seniors by shifting financial incentives from volume to outcomes, agilon health (NYSE: AGL) provides a platform that helps primary care physicians transition to value-based care models for Medicare patients through long-term partnerships and global capitation arrangements.
Why Is AGL on Our Radar?
- Market share has increased this cycle as its 30.8% annual revenue growth over the last five years was exceptional
- Earnings per share grew by 17.3% annually over the last five years and trumped its peers
- Negative free cash flow margin has improved over the last five years, showing the company is one step closer to financial self-sufficiency
agilon health is trading at $89.51 per share, or 54.2x forward P/E. Is now the right time to buy? See for yourself in our full research report, it’s free.
Brink's (BCO)
Consensus Price Target: $150.50 (38.8% implied return)
Known for its iconic armored trucks that have been a fixture in American cities since 1859, Brink's (NYSE: BCO) provides secure transportation and management of cash and valuables for banks, retailers, and other businesses worldwide.
Why Are We Fans of BCO?
- Economies of scale give it some operating leverage when demand rises
- Share repurchases have amplified shareholder returns as its annual earnings per share growth of 13.7% exceeded its revenue gains over the last five years
- Returns on capital are climbing as management makes more lucrative bets
At $108.42 per share, Brink's trades at 11.2x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Stocks We Like Even More
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.
